Discovery of a New Chalcone-Trimethoxycinnamide Hybrid with Antimitotic Effect: Design, Synthesis, and Structure—Activity Relationship Studies

In this work, the design and synthesis of a new chalcone-trimethoxycinnamide hybrid (7) based on the combination of subunits of two promising antiproliferative compounds (CM-M345 (1) and BP-M345 (2)), previously obtained by our research group, are reported. In order to expand the structure–activity relationship (SAR) knowledge, a new series of 7-analogues was also designed and synthetized. All the compounds were evaluated for their antitumor activity against melanoma (A375-C5), breast adenocarcinoma (MCF-7), and colorectal carcinoma (HCT116) cell lines, as well as non-tumor HPAEpiC cells. Three of the newly synthesized compounds (6, 7, and 13) exhibited potent antiproliferative activity, mainly on colorectal tumor cells (GI50 = 2.66–3.26 μM), showing hybrid 7 selectivity for tumor cells. We performed molecular mechanism studies to evaluate the potential interference of compounds with the p53 pathway, namely, p53–MDM2 interaction and mitosis in HCT116 cells. The antiproliferative activities of compounds were shown to be p53-independent. Compound 7 emerged as an antimitotic agent by inducing the mitotic arrest of colorectal tumor cells, and subsequently, cell death.

[1]  M. Pinto,et al.  Antitumor Effect of Chalcone Derivatives against Human Prostate (LNCaP and PC-3), Cervix HPV-Positive (HeLa) and Lymphocyte (Jurkat) Cell Lines and Their Effect on Macrophage Functions , 2023, Molecules.

[2]  Hui Poh Goh,et al.  Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives , 2022, Molecules.

[3]  M. Pinto,et al.  Bioactive Diarylpentanoids: Insights into the Biological Effects beyond Antitumor Activity and Structure–Activity Relationships , 2022, Molecules.

[4]  R. B. Bakr,et al.  Synthesis of Chalcones Derivatives and Their Biological Activities: A Review , 2022, ACS omega.

[5]  J. Tuszynski,et al.  A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization , 2022, International journal of molecular sciences.

[6]  M. Pinto,et al.  Recent Advances in Bioactive Flavonoid Hybrids Linked by 1,2,3-Triazole Ring Obtained by Click Chemistry , 2021, Molecules.

[7]  Guangcheng Wang,et al.  A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors , 2021, Journal of enzyme inhibition and medicinal chemistry.

[8]  A. Palmeira,et al.  BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity , 2021, Molecules.

[9]  A. Palmeira,et al.  A Diarylpentanoid with Potential Activation of the p53 Pathway: Combination of in silico Screening Studies, Synthesis, and Biological Activity Evaluation , 2021, ChemMedChem.

[10]  M. Pinto,et al.  Chalcones as Promising Antitumor Agents by Targeting the p53 Pathway: An Overview and New Insights in Drug-Likeness , 2021, Molecules.

[11]  M. Pinto,et al.  A New Chalcone Derivative with Promising Antiproliferative and Anti-Invasion Activities in Glioblastoma Cells , 2021, Molecules.

[12]  B. Salehi,et al.  Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence , 2021, Frontiers in Pharmacology.

[13]  M. Pinto,et al.  Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies. , 2020, European journal of medicinal chemistry.

[14]  Ana C. Henriques,et al.  Chalcone derivatives targeting mitosis: synthesis, evaluation of antitumor activity and lipophilicity. , 2019, European journal of medicinal chemistry.

[15]  Y. Madhavi,et al.  Cinnamamide: An insight into the pharmacological advances and structure-activity relationships. , 2019, European journal of medicinal chemistry.

[16]  F. Abas,et al.  Molecular Pathways Modulated by Curcumin Analogue, Diarylpentanoids in Cancer , 2019, Biomolecules.

[17]  Anand Maurya,et al.  Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review , 2019, Interventional medicine & applied science.

[18]  L. M. Lima,et al.  Natural products as new antimitotic compounds for anticancer drug development , 2018, Clinics.

[19]  A. Palmeira,et al.  Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity. , 2018, European journal of medicinal chemistry.

[20]  O. Ozdemir,et al.  Piplartine Analogues and Cytotoxic Evaluation against Glioblastoma , 2018, Molecules.

[21]  A. Palmeira,et al.  Design and synthesis of new inhibitors of p53–MDM2 interaction with a chalcone scaffold , 2016, Arabian Journal of Chemistry.

[22]  Feroz Khan,et al.  Natural antitubulin agents: importance of 3,4,5-trimethoxyphenyl fragment. , 2015, Bioorganic & medicinal chemistry.

[23]  M. Pinto,et al.  Evaluation of 2',4'-dihydroxy-3,4,5-trimethoxychalcone as antimitotic agent that induces mitotic catastrophe in MCF-7 breast cancer cells. , 2014, Toxicology letters.

[24]  Franck Danel,et al.  The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization. , 2014, Journal of molecular biology.

[25]  A. Inga,et al.  Novel simplified yeast‐based assays of regulators of p53–MDMX interaction and p53 transcriptional activity , 2013, The FEBS journal.

[26]  N. Zhang,et al.  How nanotechnology can enhance docetaxel therapy , 2013, International journal of nanomedicine.

[27]  A. Palmeira,et al.  Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach. , 2013, Biochemical pharmacology.

[28]  N. Meanwell.  Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. , 2011, Chemical research in toxicology.

[29]  Jóhannes Reynisson,et al.  Characteristics of known drug space. Natural products, their derivatives and synthetic drugs. , 2010, European journal of medicinal chemistry.

[30]  E. Barreiro,et al.  Molecular hybridization: a useful tool in the design of new drug prototypes. , 2007, Current medicinal chemistry.

[31]  M. Krawiec,et al.  Leukotriene Receptor Antagonists , 2003 .

[32]  D. E. Clark.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.

[33]  T. Goodson,et al.  Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivatives. , 1987, Journal of medicinal chemistry.

[34]  N. Garti,et al.  Basic principles of drug delivery systems - the case of paclitaxel. , 2019, Advances in colloid and interface science.